Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

NCT00022178 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Carcinoma of Unknown Primary

Interventions

DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: epirubicin hydrochloride
DRUG: fluorouracil
DRUG: vincristine sulfate

Sponsor

The Christie NHS Foundation Trust